Reilly Thomas Charles

Insider profile

Reilly Thomas Charles's trades of Cara Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
131.09
Quantity 18,756 +30.5%
Value US$2,362,963
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-03-04 2022-03-03 PlS Planned sale
18,756 +30.5%
131.09
US$2,362,963
18,756 +30.5% 131.09 US$2,362,963